Oncology Firm TransCode Therapeutics Looks To Raise US$25 Million In IPO

Oncology company TransCode Therapeutics, Inc. is set to begin publicly trading its equityon the Nasdaq Capital Market today under the symbol “RNAZ.” The company is looking to raise an aggregate sum of US$25.0 million in its initial public offering.

The offering will consist of 6,250,000 common shares priced at US$4.00 per share. The underwriters were also granted a 45-day over-allotment option to purchase an additional 937,500 common shares at the same offering price, bringing the possible proceeds of the offering to US$28.8 million.

In its statement, TransCode refers to itself as an RNA oncology company centered on the belief that cancer can be addressed through RNA therapeutics. Proceeds from the offering will be intended to progress the trial and develop its therapeutic candidate, TTX-MC138, which is focused on treating metastatic cancer.

The offering is expected to close on July 13, 2021, subject to customary closing conditions. Fordham Financial division ThinkEquity acts as the sole underwriter for the offering.


Information for this briefing was found via Sedar and TransCode. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

Giant Mining Encounters Native Copper As Hole MHB-34 Hits 563 Metres Depth

Verses Hits Commercialization Stage With Genius AI Platform

Related News

Jeb Bush-Chaired Healthcare SPAC Jackson Acquisition Prices US$200 Million IPO

Special purpose acquisition company Jackson Acquisition Company (NYSE: RJAC.U) went public today on the New...

Thursday, December 9, 2021, 02:17:00 PM

SPAC Chavant Capital Acquisition Seeks To Raise US$80 Million In IPO

Special purpose acquisition company Chavant Capital Acquisition Corp. went public on Nasdaq Capital Market today....

Tuesday, July 20, 2021, 11:38:00 AM

Fintech SPAC SHUAA Partners Acquisition I Prices US$100 Million IPO

Special purpose acquisition company SHUAA Partners Acquisition Corp I (Nasdaq: SHUAU) started trading its securities...

Thursday, March 3, 2022, 02:27:00 PM

Silver Mountain Resources Seeks To Raise $23 Million In TSXV IPO

Mining firm Silver Mountain Resources Inc. is looking to go public on the TSX Venture...

Monday, January 24, 2022, 02:20:00 PM

Tech SPAC AxonPrime Infrastructure Acquisition Conducts US$150 Million IPO

Special purpose acquisition company AxonPrime Infrastructure Acquisition Corporation (Nasdaq: APMIU) started trading publicly on the...

Monday, August 16, 2021, 10:49:00 AM